Effects of Tamiflu still uncertain, warn experts, as Roche continues to withhold key trial data, according to new report

Two years after pharmaceutical giant Roche promised the British Medical Journal it would release key Tamiflu trial data for independent scrutiny, the safety and effectiveness of this anti-influenza drug remains uncertain, warn experts. A new report by the Cochrane Collaboration says Roche's refusal to provide full access to all its data leaves critical questions about how well the drug works unresolved.

Read the whole article on Science Daily

More from Science Daily